1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Surgeon influence on receipt of contralateral prophylactic mastectomy for breast cancer
    Meeting Abstract

    Katz, S. J.; Morrow, M.; Hawley, S. T.; Jagsi, R.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Avelumab in chemotherapy-refractory metastatic Merkel cell carcinoma: Subgroup analysis of efficacy
    Meeting Abstract

    Kaufman, H. L.; Russell, J.; Hamid, O.; Bhatia, S.; Terheyden, P.; D'Angelo, S. P.; Shih, K. C.; Lebbe, C.; Linette, G. P.; Milella, M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Brain metastases (BM) in pancreatic ductal adenocarcinoma (PDAC): Clinical and molecular characteristics
    Meeting Abstract

    Jordan, E.; Kaley, T. J.; Capanu, M.; Estrella, H.; Leach, S. D.; Basturk, O.; Klimstra, D. S.; Allen, P. J.; Berger, M. F.; Yu, K. H.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Restoration of tumor suppression in vivo by systemic delivery of chemically-modified PTEN mRNA nanoparticles
    Meeting Abstract

    Islam, M. A.; Xu, Y.; Zope, H.; Cao, W.; Mahmoudi, M.; Langer, R.; Kantoff, P. W.; Shi, J.; Zetter, B. R.; Farokhzad, O. C.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Consensus treatment guidelines for urgent symptoms in cholangiocarcinoma (CC) patients (pts) with biliary stents or catheters using the modified RAND/UCLA Delphi process
    Meeting Abstract

    Iyer, R. V.; Acquisto, S. G.; Bridgewater, J. A.; Choti, M. A.; Hong, T. S.; Kis, B.; Mead, P. A.; Parikh, N. D.; Roberts, L. R.; Roberts, R.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Guidelines for management of urgent symptoms in cholangiocarcinoma (CC) patients (pts) with biliary stents or catheters using the modified RAND/UCLA Delphi process
    Meeting Abstract

    Iyer, R. V.; Acquisto, S. G.; Bridgewater, J. A.; Choti, M. A.; Hong, T. S.; Kis, B.; Mead, P. A.; Roberts, L. R.; Roberts, R.; Parikh, N. D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine (G), trastuzumab (H), and pertuzumab (P) for HER2-positive metastatic breast cancer (MBC) after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P. A.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Treatment decisions and employment of breast cancer patients: Results of a population-based survey
    Meeting Abstract

    Jagsi, R.; Abrahamse, P.; Lee, K.; Wallner, L. P.; Janz, N. K.; Hamilton, A. S.; Ward, K. C.; Morrow, M.; Kurian, A. W.; Friese, C. R.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Survival outcomes of the NeoALTTO study: Updated results of a randomized multicenter phase III neoadjuvant trial
    Meeting Abstract

    Huober, J. B.; McCormick Holmes, E.; Baselga, J.; De Azambuja, E.; Untch, M.; Fumagalli, D.; Sarp, S.; Lang, I.; Smith, I. E.; Boyle, F. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Two randomized, placebo-controlled phase 3 studies of ruxolitinib (Rux) + capecitabine (C) in patients (pts) with advanced/metastatic pancreatic cancer (mPC) after failure/intolerance of first-line chemotherapy: JANUS 1 (J1) and JANUS 2 (J2)
    Meeting Abstract

    Hurwitz, H.; Van Cutsem, E.; Bendell, J. C.; Hidalgo, M.; Li, C. P.; Garrido, M.; Macarulla, T. M.; Sahai, V.; Sama, A. R.; Greeno, E.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save